First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?

Twitter summary: Major updates from @MDT_Diabetes on the 640G predictive #insulin suspend for #diabetes from #ATTD2015

Incredible enthusiasm continues for the 14-day sensor that replaces fingersticks.

Submitted to the FDA and could be approved this year.

How this two-week trial looks to bring the Libre technology to health care.

What this dramatic movement in obesity therapy means for patients in Europe.

Twitter summary: UCSF launches SugarScience, an initiative on sugar’s dangerous health impacts. Visit SugarScience.org for more information A group of health scientists...

What I learned from doubling my carb intake: more work, more danger, but the same average blood sugar. Huh?

The two organizations expand their research partnership to support glucose responsive insulin.

Plus, exciting details on Google’s glucose-sensing contact lens!

My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”

Accu-Chek Connect System to be released on August 7 for $29.99.

New blinded sensor worn for 14 days that will give a detailed picture of your glucose levels.

What this news means for the future of data integration, and what the “real magic” will be down the road.

Why we’re fans of the newest Bluetooth-enabled meter with an FDA-approved bolus advisor app.

Bringing added convenience to blood glucose monitoring in smartphone-connected device.

Plus, a first look at the Google/Dexcom bandage-like CGM and the smart new Clarity software.

IBM and Medtronic announce the first product out of their innovative partnership.

Smartphone user interface with no screen or buttons on the pump! Launch: 2018?

Shipping now! Patients must decide between data on the phone or pump.